Simultaneous in situ detection of mRNA and apoptotic cells by combined hybridization and TUNEL.
Author(s) -
Jörn Sträter,
Henning Walczak,
Peter H. Krammer,
Peter C. Möller
Publication year - 1996
Publication title -
journal of histochemistry and cytochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 124
eISSN - 1551-5044
pISSN - 0022-1554
DOI - 10.1177/44.12.8985142
Subject(s) - tunel assay , dna fragmentation , in situ hybridization , microbiology and biotechnology , digoxigenin , apoptosis , biology , hybridization probe , in situ , apoptotic dna fragmentation , immunogold labelling , fragmentation (computing) , dna , chemistry , messenger rna , gene , programmed cell death , biochemistry , antibody , genetics , ecology , organic chemistry
We established a new method to allow simultaneous in situ detection of mRNA expression and apoptotic DNA fragmentation in paraffin-embedded tissue sections. We used human thymic tissue to perform in situ hybridization with a digoxigenin-labeled CD95 (APO-1/Fas) ligand (CD95L)-specific probe followed by TdT-mediated biotin dUTP nick end-labeling (TUNEL) of apoptotic DNA fragments. Bound probes were visualized by an immunogold-silver enhancement technique and fragmented DNA was detected with a streptavidin-peroxidase system. This double labeling technique produced a distinct, dark cytoplasmic staining of CD95L mRNA-expressing cells and an intense red nuclear precipitate in apoptotic cells or bodies. This technique will be a useful tool for microtopographical analysis of apoptosis-related gene expression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom